By Orbex
Two weeks ago, The Bureau of Investigative Journalism (BIJ) published an explosive article in which they accused Pfizer of holding Latin American countries to ransom over the coronavirus vaccine.
The allegations were pretty harsh, but they didn’t get much traction in the mainstream media.
That hasn’t stopped the story from circulating online. So far, Pfizer has not responded to the charges, leaving many investors questioning… what’s really going on?
The allegations
Two countries in Latin America didn’t reach a deal with Pfizer: Argentina and Brazil.
Both countries publicly accused the pharmaceutical giant of abusive negotiations. However, why the report from the BIJ got special attention is that it said that Pfizer had demanded that countries put up sovereign collateral, such as military bases or embassies.
Free Reports:
Get our Weekly Commitment of Traders Reports - See where the biggest traders (Hedge Funds and Commercial Hedgers) are positioned in the futures markets on a weekly basis.
Download Our Metatrader 4 Indicators – Put Our Free MetaTrader 4 Custom Indicators on your charts when you join our Weekly Newsletter
Without the context, it seems extraordinary that a pharmaceutical company would demand such things.
The BIJ report is based on anonymous sources from the Argentine ministry of health and an unnamed Latin American country. These officials declined to be named citing confidentiality agreements over the negotiations – the same reason Pfizer gave for not responding to the report.
What’s really going on
Because these kinds of negotiations are secret, it’s virtually impossible to know for sure what actually transpired.
However, we can verify certain things based on public statements that aren’t disputed.
It is normal during pandemics for pharmaceutical companies to require indemnity when manufacturing and distributing a new medication that has been rushed in the midst of a pandemic.
Typically, this means that should something go wrong with the medication, then the company isn’t held liable. Instead, the governments who authorized the use and distribution of the medication take responsibility for compensating for potential side effects.
This was part of the negotiations for the last N1H1 vaccine, and has been agreed to by every major country.
OK, but what about the military bases?
An unnamed official from the Argentine Ministry of Health says that in late December, Pfizer demanded that the country put up sovereign assets as collateral.
The official explained that this had been done before in the context of debt negotiations, but was unprecedented in this case. Of course, we should ntoe that Argentina has a very troubled history when it comes to paying its debts.
In fact, in 2012 a hedge fund seized a military vessel of the Argentine Navy in Ghana over unpaid sovereign bonds.
The problem with the story is that so far, we only have this one unnamed official’s view that it happened. There is no official corroborating evidence.
Argentina says they refused to buy Pfizer’s vaccine because of abusive demands from the company. Instead, they have relied heavily on Russian and Chinese suppliers.
The confidentiality agreements last five years. And likely, we will have to wait until then to know for sure what really happened.
By Orbex

- COT Metals Charts: Copper leads Metals Speculator Bets Higher Apr 26, 2026
- COT Bonds Charts: Speculator Bets led by 5-Year Bonds & Ultra 10-Year Bonds Apr 26, 2026
- COT Energy Charts: Weekly Speculator Bets led by Natural Gas Apr 26, 2026
- COT Soft Commodities Charts: SoyOil lead Speculator Bets Apr 26, 2026
- The Middle East conflict is already driving inflation higher across the world Apr 24, 2026
- Gold Falls Nearly 3.0% Over the Week Amid Geopolitical Pressure Apr 24, 2026
- The diplomatic deadlock between the US and Iran is undermining investors’ appetite for risk Apr 23, 2026
- EUR/USD Falls for Third Day as Geopolitics and Strong Dollar Dictate Terms Apr 23, 2026
- Negotiations between the US and Iran have failed. Oil prices are back above 90 dollars per barrel Apr 22, 2026
- USD/JPY Pulls Higher: Yen Doubts Bank of Japan Apr 22, 2026